Students can search the internet to determine the current economic and political climate in
China. For example, see
www.wsj.com/articles/american-companies-say-doing-business-in-china-is-getting-tougher-1
453260461.
Marketing Ethics: Cleaning Up the Chinese Pharmaceutical Market
By 2020, the Chinese pharmaceutical market will be worth $1.3 trillion per year. Pharmaceutical
businesses from around the world have recognized the potential of the market and, at the same
time, existing Chinese businesses have realized the potential threats to their market share. In
order to grab some market share and profit, some pharmaceutical companies have been less than
honest in their dealings and have subsequently found themselves under intense scrutiny from
China’s National Development and Reform Commission (NDRC). In 2016, the NDRC fined 5
domestic pharmaceutical companies over $600,000 for fixing their prices. This was part of the
continuing battle to keep medicine prices at affordable levels. The 5 companies had colluded
between April 2014 and September 2015 to raise the price of a drug used to treat kidney diseases.
China has 1.4 billion potential customers, and the drug market was growing at 20 percent a year;
it has now slowed to 5 percent.
The Chinese government is keen to stamp out corruption, but corruption is ingrained and
persistent. China ranks 79th out of 175 countries on the Transparency International Index 2016,
which tracks corruption across a variety of business markets. In one corruption case, the
corruption took place outside of the normal parameters of business dealings; the individuals
made deals outside the company’s systems. In this particular case, there was a 30 percent drop in
sales as the company scaled back in order to ensure it had oversight of all aspects of business
operations in China. If foreign companies are found by the NDRC to be giving out bribes, then it
is not just a question of business as usual after paying the fine; they must also repair their
reputations.
19-11 Should pharmaceutical companies learn to adapt to paying bribes in China? Debate
both sides of this issue. (AACSB: Communication; Ethical Reasoning)
Answer: Student answers will vary. It would seem that many pharmaceutical companies are
doing this as many are being investigated by the NDRC. It is thus clear that the Chinese
government wants to stamp out corruption. There have been some very high profile court
19-12 Discuss whether multinational companies have difficulties breaking into the market in
your country.
Answer:
Student answers will vary. Student responses will depend on the nature of the market, its
size, and any potential barriers to entry. The barriers may include legislature, the nature of the